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The XC rat sarcoma cell line undergoes extensive cell-to-cell fusion (syncytium formation) after infection with ecotropic
murine leukemia viruses (MLVs) and is frequently used to titrate these viruses. This cell line is unique in its response to the
ecotropic MLV envelope (Env) protein in that it undergoes syncytium formation with cells expressing Env protein containing
R peptide (R Env), which is known to suppress the fusogenic potential of the Env protein in other susceptible cells. To
assess whether this property of the XC cell line arises from differences in its ecotropic MLV receptor, CAT1, we isolated CAT1
cDNA clones from XC cells. A variant CAT1 (xcCAT1) was found together with the wild-type rat CAT1 (rCAT1). xcCAT1 cDNA
encodes a protein with a single amino acid change that destroys a conserved N-linked glycosylation site proximal to the
Env-binding motif. We found that xcCAT1 expressed in Chinese hamster ovary (CHO) cells undergoes less glycosylation than
rCAT1 and that the expression of xcCAT1 rendered the CHO cells more susceptible to infection with Moloney MLV. Thus,
N-glycosylation negatively regulates the receptor activity of rCAT1. This is supported by the observation that treatment of rat
F10 cells with the N-glycosylation inhibitor tunicamycin enhanced their susceptibility to Mo-MLV. However, xcCAT1-
expressing CHO cells did not fuse with 293T cells expressing R Env, indicating that xcCAT1 expression is not sufficient totia in re
o acidINTRODUCTION
Entry of enveloped viruses into host cells is initiated by
binding of the viral envelope protein to the cellular re-
ceptor for infection, after which the viral envelope fuses
with cellular membranes (Chan and Kim, 1998; Skehel
and Wiley, 1998; White, 1992). The envelope (Env) protein
of the ecotropic Moloney murine leukemia virus (Mo-
MLV) is synthesized as a precursor polyprotein and is
proteolytically cleaved into surface and transmembrane
(TM) subunits during its transport to the cell surface
(Schult and Rein, 1985). The C-terminal 16 amino acids (R
peptide) of the TM protein is further cleaved in the virions
by the viral protease (Green et al., 1981; Henderson et al.,
1984). The R peptide appears to negatively control the
membrane fusion activity of the Env protein as the Mo-
MLV Env protein genetically engineered to lose the R
peptide (R-Env) causes receptor-mediated syncytium for-
mation when expressed in susceptible cells, unlike the
wild-type Env protein bearing the R peptide (R Env)
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338(Melikyan et al., 2000; Ragheb and Anderson, 1994; Rein
et al., 1994). Such syncytium formation is thought to
correspond to the fusion between the viral envelope and
the host cell membranes that precedes viral entry.
The rat XC cell line, which was established from a
Raus sarcoma virus-induced tumor, differs from other
lines in that it undergoes syncytium formation in re-
sponse to the R Env protein (Jones and Risser, 1993).
Consequently, the XC cell line is widely used to titrate
ecotropic MLVs, as the number of plaques resulting from
the syncytium formation correlates with the viral titer
(Klement et al., 1969; Rowe et al., 1970). Why the XC cell
line has this unique property is unclear. One possibility is
that its ecotropic MLV receptor, CAT1 (cationic amino
acid transporter 1) (Albritton et al., 1989), differs in some
way. In the study reported here, we have investigated
this issue by cloning and characterizing cDNAs from XC
cells that encode CAT1. In addition to the wild-type rat
CAT1 (rCAT1) previously reported (Takase-Yoden and Wa-
tanabe, 1999; Wu et al., 1994), we obtained clones en-
coding a variant form of rCAT1. This variant, denoted
xcCAT1, contained a single amino acid substitution that
abolished the conserved consensus sequence for N-
linked glycosylation near the Env-binding motif (Albritton
et al., 1993; Yoshimoto et al., 1993). xcCAT1 expression ininduce the XC cell-specific characteristic of forming syncy
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Chinese hamster ovary (CHO) cells increased their sus-
ceptibility to the Mo-MLV vector relative to rCAT1 expres-
sion. These and other observations (Tavoloni and Ruden-
holz, 1997) collectively indicate that the N-glycosylation
of rCAT1 downregulates its ecotropic receptor activity.
Thus, XC cells are more susceptible to the first stage of
Mo-MLV infection, namely, the binding of the virus to its
ecotropic receptor. However, we also found that xcCAT1-
expressing CHO cells fused with R Env-expressing
293T cells and formed syncytia but not with R Env-
expressing cells. Thus, xcCAT1 expression is not suffi-
cient to endow the XC cell-specific characteristic of form-
ing syncytia in response to R Env.
RESULTS
Isolation of CAT1 cDNA clones from XC cells
CAT1 cDNA clones were isolated from rat XC cells by
the RT-PCR method. The PCR primers were based on the
published nucleotide sequence of rCAT1 cDNA (Takase-
Yoden and Watanabe, 1999; Wu et al., 1994). The sense
and antisense PCR primers contained the translation
initiation and the termination codons, respectively, but
not the sequences coding for the rest of the rCAT1
protein. The nucleotide sequences of two cDNA clones
were determined. Both contained an open reading frame
encoding a protein of 624 amino acids, the same number
of amino acids as the rCAT1 protein. One clone (clone 1)
had eight nucleotides that differed from the reported
sequence of rCAT1 cDNA and the deduced amino acid
sequence had a single amino acid change from the
rCAT1 protein. The other clone (clone 2) had seven nu-
cleotide changes that did not cause amino acid changes
and also occurred in clone 1. Thus, the nucleotide
change unique to clone 1 resulted in the single amino
acid substitution of Asn 231 by Asp (Fig. 1). The CAT1
cDNA of clone 1 is designated here as xcCAT1.
To confirm that the unique nucleotide change found in
xcCAT1 cDNA was not an artifact caused by the isolation
procedures we used, including reverse transcription and
PCR, additional cDNA clones encompassing the 171-bp
sequence of rCAT1 that included the site of the unique
nucleotide change were independently isolated from XC
cells by RT-PCR. The nucleotide sequences of 12 clones
were determined. Three had the same unique nucleotide
change (A to G) as xcCAT1, while the other clones had
the same sequence as clone 2 (data not shown). Thus,
XC cells express a variant form of rCAT1 (xcCAT1) as well
as the wild-type rCAT1.
The Asn 231 residue of rCAT1 is located in the putative
third extracellular loop and participates in the consensus
sequence (N-X-T/S) for N-linked glycosylation. This N-
glycosylation site and another site located several amino
acids upstream toward the N-terminus are conserved in
the CAT1 proteins from many species, including mice
(Albritton et al., 1989), Mus dunni, Chinese hamsters,
Syrian hamsters (Eiden et al., 1993, 1994), Armenian
hamsters (Masuda et al., 1996a), mink, and humans (Yo-
shimoto et al., 1991) (Fig. 1). The N231D change in xc-
CAT1 will thus most likely result in loss of glycosylation
at this site.
FIG. 1. Deduced amino acid sequences of a portion of the putative third extracellular loop of the CAT1 proteins isolated from various sources.
Conserved consensus sequences for N-linked glycosylation are boxed. The presumed Env-binding site in mouse CAT1 is underlined. The single
amino acid substitution detected in the mutant CAT1 isolated from XC cells is indicated by double underlining.
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xcCAT1 undergoes less glycosylation than rCAT1
The N231D change suggests that the xcCAT1 glycop-
rotein will be smaller than rCAT1. To assess this, expres-
sion plasmids encoding rCAT1, xcCAT1, and mouse CAT1
(mCAT1) tagged with an influenza hemagglutinin (HA)
epitope were constructed, CHO cells were transfected,
and Western blot analysis with the anti-HA epitope
monoclonal antibody was performed. As shown in Fig. 2,
the xcCAT1 protein was significantly smaller than the
mCAT1 and rCAT1 proteins. However, treatment of the
three transfected CHO cell types with the N-glycosylation
inhibitor tunicamycin resulted in faster moving CAT1 pro-
tein bands of a equivalent molecular size (Fig. 2). Thus,
the N231D substitution indeed prevents the full N-glyco-
sylation of xcCAT1.
xcCAT1-expressing CHO cells are more susceptible
to Mo-MLV vector transduction than
rCAT1-expressing cells
We investigated whether expressing xcCAT1 would
make the host cells more susceptible to Mo-MLV vector
transduction. We tested this by measuring the transduc-
tion titer of the Mo-MLV vector in CHO cells transiently
transfected with various amounts of the HA-tagged
rCAT1 or xcCAT1 expression plasmids. For both plas-
mids, the levels of CAT1 protein expressed depended on
the plasmid dose (Fig. 3).
Higher amounts of the xcCAT1-HA expression plasmid
induced higher transduction titer in the range from 0.1 to
1.0 g of the plasmid (Fig. 4). Although the highest level
of xcCAT1-HA protein was detected in CHO cells trans-
fected with 3.0 g of the expression plasmid, transduc-
tion titer of Mo-MLV vector in those cells was lowest.
Transduction titer in CHO cells transfected with 0.5 g of
the rCAT1-HA expression plasmid was higher than in 0.1
g of the plasmid. Higher amounts of the rCAT1-HA
expression plasmid, however, induced lower transduc-
tion titer of Mo-MLV vector in the range from 0.5 to 3.0 g
of the plasmid. This result suggests that a higher amount
FIG. 2. xcCAT is less glycosylated than rCAT1. CHO cells transiently
transfected with the HA epitope-tagged mCAT1, rCAT1, and xcCAT1
constructs were cultured in the absence or presence of tunicamycin for
48 h. Cell lysates were prepared and analyzed by Western blotting
using the anti-HA epitope monoclonal antibody. CHO cells transfected
with the pUC plasmid were used as controls.
FIG. 3. CAT1-HA protein levels in CHO cells transfected with various
amounts of the rCAT1-HA or xcCAT1-HA expression plasmids. CHO
cells were transfected with various amounts of the rCAT1-HA or
xcCAT1-HA expression plasmids. Cell lysates were prepared and an-
alyzed by Western blotting using the anti-HA epitope monoclonal anti-
body.
FIG. 4. Transduction titers in CHO cells transfected with various
amounts of the rCAT1-HA or xcCAT1-HA expression plasmids.
rCAT1-HA is shown by an open circle and xcCAT1-HA by a closed
circle. Shown are transduction titers relative to the value of CHO cells
transfected with 10 g xcCAT1-HA expression plasmid.
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of the plasmids damages CHO cells more severely and
induces lower transduction titer of Mo-MLV vector.
The transduction titer in CHO cells transfected with 0.5
g of rCAT1-HA expression plasmid was lower than that
with 0.1 g xcCAT1-HA expression plasmid, even though
the amount of rCAT1-HA protein was clearly higher than
that of xcCAT1-HA. This result indicates that xcCAT1 is
more susceptible to Mo-MLV vector transduction than
rCAT1.
The xcCAT1-HA-expressing CHO cells fused with R
Env-expressing human 293T cells and formed syncytia,
but did not with R Env-expressing cells (data not
shown). This result indicates that the xcCAT1 is not
sufficient for the XC cell-specific syncytium formation by
R Env protein.
Tunicamycin treatment makes F10 cells more
susceptible to Mo-MLV
The observations above suggest that N-glycosylation
at the site proximal to the Env-binding motif downregu-
lates the ability of rCAT1 to function as the ecotropic MLV
receptor. Supporting this notion is that treatment of ham-
ster cells, such as CHO, BHK (Karreman et al., 1996;
Miller and Miller, 1992), and THK (T. Ono and A. Ishimoto,
unpublished observations), with the N-glycosylation in-
hibitors tunicamycin or sialidase makes the cells sus-
ceptible to Mo-MLV infection. Furthermore, some CHO
cell glycosylation mutants are also susceptible to Mo-
MLV infection (Eiden et al., 1994). Thus, we assessed
whether treating rat F10 cells with tunicamycin would
render these cells more susceptible to Mo-MLV. As
shown in Fig. 5, transduction titers in tunicamycin-
treated F10 cells were significantly increased compared
to the titers in nontreated F10 cells. In contrast, the
transduction titers in NIH 3T3 and XC cells were not
increased by tunicamycin treatment. Thus, the N-linked
glycosylation downmodulates the viral receptor activity
of rCAT1.
Tunicamycin-treated F10 cells cultured with R Env-
expressing 293T cells formed syncytia, but did not with
R Env-expressing cells (data not shown). This result
supports the result that xcCAT1 expression is not suffi-
cient to endow the XC cell-specific characteristic of form-
ing syncytia in response to R Env.
DISCUSSION
N-glycosylation near the Env-binding motif of the rat
ecotropic MLV receptor downregulates virus binding
CAT1 is the ecotropic MLV receptor. When we per-
formed RT-PCR on mRNA prepared from rat XC cells to
clone CAT1 cDNA, we isolated a clone encoding a vari-
ant of CAT1 cDNA, denoted xcCAT1. The xcCAT1 protein
has a single amino acid substitution at the N-linked
glycosylation site near the Env-binding motif (Albritton et
al., 1993; Yoshimoto et al., 1993) (Fig. 1). Western blotting
analysis revealed that xcCAT1 is a smaller glycoprotein
than the wild-type rCAT1 glycoprotein due to its reduced
glycosylation (Fig. 2). xcCAT1 expression increased the
susceptibility to Mo-MLV vector transduction relative to
rCAT1 in CHO cells (Fig. 4) and treatment of rat F10 cells
with the N-glycosylation inhibitor tunicamycin rendered
these cells more susceptible to Mo-MLV entry (Fig. 5).
Thus, the N-glycosylation at the Asn 231 residue of the
wild-type rCAT1 negatively regulates Mo-MLV infection.
This notion is supported by previously published obser-
vations that tunicamycin or sialidase treatment renders
hamster and rat cells more susceptible to the Mo-MLV
infection (Tavoloni and Rudenholz, 1997; Karreman et al.,
1996; Miller and Miller, 1992; Wilson and Eiden, 1991),
and that glycosylation mutants of the CHO cell line are
susceptible to Mo-MLV infection (Eiden et al., 1994).
It is possible that the N-glycosylation of CAT1 has
arisen as a defense against ecotropic MLV infection,
especially since it appears that the N-glycosylation sites
of CAT1 do not participate in the primary cationic amino
acid transporter function of this protein. This is shown by
the fact that mCAT1 mutants with amino acid substitu-
tions at the N-linked glycosylation site are equally active
cationic amino acid transporters as the wild-type mCAT1
(Wang et al., 1996). It has also been reported that core-
ceptor glycosylation modulates the susceptibility of cells
to human immunodeficiency viruses (Chabot et al., 2000;
Potempa et al., 1997; Talbot et al., 1995).
How N-glycosylation could affect susceptibility to Mo-
MLV is not clear, although it most likely abrogates or
reduces the binding of the receptor to the Env protein of
Mo-MLV. It is unlikely that it regulates the cell-surface
expression of the receptor because previous studies
have shown that the cell-surface expression of the CAT1
FIG. 5. Effect of tunicamycin on the susceptibility of various cell lines
to Mo-MLV. Transduction titers of the Mo-MLV vector in NIH 3T3 (open
circles), XC (open squares), and F10 (closed circles) cells treated with
various concentrations of tunicamycin for 24 h are indicated. Treatment
with 200 ng/ml tunicamycin killed many XC cells.
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protein of mice and M. dunni is not inhibited by artificial
mutations that abrogate N-glycosylation (Kim and Cun-
ningham, 1993; Wang et al., 1996; Eiden et al., 1994).
Tunicamycin treatment of hamster cells also does not
reduce CAT1 protein expression on the cell surface (Mil-
ler and Miller, 1992; Wilson and Eiden, 1991).
It should be noted that some published observations
suggest that N-glycosylation of CAT1 may not be the only
factor regulating Mo-MLV infection. First, while hamster
cells are almost completely resistant to Mo-MLV infec-
tion (Wilson and Eiden, 1991), rat F10 cells are slightly
susceptible (Takase-Yoden and Watanabe, 1999), despite
the fact that the CAT1 from rats and hamsters share the
same conserved N-glycosylation sites. Furthermore,
mouse cells, which also have the conserved N-glycosyl-
ation sites, are highly susceptible to ecotropic MLV in-
fection (Fig. 1) and artificial substitutions at these sites
that abrogate glycosylation of the mouse receptor do not
alter the in vitro susceptibility of the cells to MLV infec-
tion (Kim and Cunningham, 1993; Wang et al., 1996).
However, it is possible that different degrees of glyco-
sylation of the receptor in different cell types may be
responsible for the cell-type specific susceptibilities to
infection with ecotropic MLVs in vivo. Isolating CAT1
cDNA clones from many other species and performing
functional analysis may better clarify the purpose of the
N-glycosylation sites in CAT1.
Notably, N-glycosylation of CAT1 appears to have no
effect on infection with the closely related Friend MLV
(Fr-MLV). It has been reported that while the N-glycosyl-
ation of M. dunni CAT1 inhibits infection with Mo-MLV,
the cells remain susceptible to infection with Fr-MLV
(Eiden et al., 1993, 1994). Furthermore, Fr-MLV can infect
hamster cells (Ishimoto, 1985), which are completely
resistant to Mo-MLV infection (Wilson and Eiden, 1991).
In addition, neuropathogenic MLVs derived from Fr-MLV
(Kai and Furuta, 1984; Masuda et al., 1992; Takase-Yoden
and Watanabe, 1997) are known to infect hamster and rat
cells more efficiently than non-neuropathogenic MLVs
(Masuda et al., 1996a,b; Takase-Yoden and Watanabe,
1999). This indicates that Fr-MLV, together with neuro-
pathogenic MLVs, may have evolved a mechanism to
overcome the inhibition imposed by receptor glycosyla-
tion.
Role of xcCAT1 in XC cells
It is clear that the presence of xcCAT1 increases the
susceptibility of the host cells to Mo-MLV infection. We
do not know whether the rat from which the XC cell line
was derived expressed xcCAT1 or if xcCAT1 appeared
during the cellular transformation by the Raus sarcoma
virus or during the maintenance of the XC cell line.
However, it is clear that the unique nucleotide change
we found in the xcCAT1 cDNA did not result from the
cDNA isolation procedures that we used since we could
isolate several independent RT-PCR clones with the
same nucleotide change. Furthermore, that tunicamycin
treatment of XC cells did not increase their susceptibility
to Mo-MLV infection (Fig. 5) strongly supports the notion
that XC cells express xcCAT1.
It is curious that tunicamycin treatment of XC cells
does not increase their susceptibility to Mo-MLV infec-
tion, as these cells express rCAT1 as well as xcCAT1. It
may be that the available xcCAT1 saturates the receptor
activity of the cell. This is supported by the observation
that CHO cells expressing low levels of xcCAT1 protein
were transduced efficiently by Mo-MLV vector (Figs. 3
and 4).
Syncytium formation in XC cells by the R Env
protein
XC cells are unusual in that they form syncytia in
response to both the R and the R Env proteins.
Normally, the membrane-fusion potential of the Env pro-
tein is activated only after R peptide cleavage (Melikyan
et al., 2000; Ragheb and Anderson, 1994; Rein et al.,
1994). Thus, in cells such as NIH 3T3 and F10, only the
R Env protein, not the R Env protein, induces syncy-
tium formation. We initiated our investigation of the CAT1
isolated from XC cells to determine why XC cells can
form syncytia in response to the R Env protein. We
found that CHO cells expressing xcCAT1 formed syncytia
when they were cultured with R Env-expressing 293T
cells but not when they were cultured with R Env-
expressing 293T cells. Thus, xcCAT1 expression is not
sufficient to endow the XC cell-specific property of form-
ing syncytia in response to the R Env protein. However,
as xcCAT1-expressing cells are obviously more suscep-
tible to ecotropic MLV infection than rCAT1-expressing
cells, it is still possible that xcCAT1 could contribute to
the R Env protein-induced syncytium formation of XC
cells. However, there are clearly also other factors in the
XC cell line that are responsible for its exceptional re-
sponse to the R Env protein. Further studies on this
issue may aid our understanding of the mechanisms by
which Env protein-mediated membrane fusion occur and
how the CAT1 protein is regulated as a viral receptor.
MATERIALS AND METHODS
CAT1 cDNA clones
CAT1 cDNA was cloned from XC cells by the RT-PCR
method using LA Taq DNA polymerase (Takara) and the
R1 and R2 primers. Total RNA was extracted from XC
cells and used for random oligonucleotide-primed re-
verse transcription to produce the single-stranded
cDNAs (LA RNA PCR kit, Takara). The sequences of the
R1 and R2 primers were 5-TTACTGCAGACAGATTTGCT-
CAGCGCGATG-3 and 5-TGTCACCTTGGTGGGTGGGG-
CTGTGGGTCA-3, respectively. The LA Taq DNA poly-
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merase has a proofreading activity and high fidelity (Bar-
nes, 1994; Cheng et al., 1994). The PCR primers were
synthesized by Nisshinbo Inc. according to the reported
sequence of rCAT1 (Takase-Yoden and Watanabe, 1999;
Wu et al., 1994). The PCR products were inserted into the
pTargeT expression vector (Promega) by TA ligation. Nu-
cleotide sequences were determined using the ABI
PRISM 377 sequencer at Fasmac Co. For cDNA cloning
of a portion of rCAT1 from XC cells by the RT-PCR
method, R3 (5-AAATCCAGTCCTCTCTGTGGGAAC-3)
and R4 (5-CTTCTGGGGGTTCTTGACTTCTTC-3) were
used. These primers were designed to amplify the se-
quence encoding a segment of the putative third extra-
cellular loop of rCAT1. Cloned cDNAs for rCAT1 (Takase-
Yoden and Watanabe, 1999) and mCAT1 (Albritton et al.,
1989) were kindly provided by R. Watanabe (Soka Uni-
versity, Tokyo) and J. M. Cunningham (Harvard Medical
School, MA), respectively. Expression plasmids for
mCAT1, rCAT1, and xcCAT1 tagged with the HA epitope
were constructed by the PCR-mediated method using
the following primers: 5-TTACTGCAGACAGATTTGCTCA-
GCGCGATG-3 and 5-TCATGCGTAATCCGGAACATCGT-
ACGGGTATTTGCACTGGTCCAAGTTGCTGTCAGGAGTC-
TT-3. The latter antisense primer contains the HA
epitope sequence.
Cell growth, transfection, and tunicamycin treatment
Mouse embryo fibroblast NIH 3T3, rat glial F10 (Sun,
1991), rat sarcoma XC, human embryo kidney 293T, and
human TELCeB6 (Cosset et al., 1995) cells were cultured
in Dulbecco’s modified Eagle’s medium (Sigma) at 37°C
in 5% CO2. Chinese hamster ovary fibroblast CHO-K1
cells were cultured in Ham’s F-12 nutrient mixture me-
dium (Gibco-BRL). The culture media were all supple-
mented with 8% fetal bovine serum (FBS) (HyClone).
For analysis of the molecular weights of the HA
epitope-tagged CAT1 proteins, semiconfluent cultures of
CHO cells were transfected for 48 h in the presence or
absence of 100 ng/ml tunicamycin (Sigma) with each of
the HA-tagged CAT1 expression plasmids using the
TransIT-LT1 polyamine reagent (Mirus). Cell lysates were
then prepared by the RIPA buffer on ice and aliquots
containing 70 g protein were subjected to 7.5% SDS–
polyacrylamide gel electrophoresis and subsequent
Western blotting using the mouse anti-HA epitope mono-
clonal antibody (1:2000 dilution) (Covance) and horserad-
ish peroxidase (HRP)-conjugated anti-mouse IgG (Bio-
Rad).
To determine the susceptibility of transfected CHO
cells to the ecotropic virus vector, 24 h after inoculation
of 1  105 CHO cells into 60-mm dishes, the cells were
transfected with various amounts of the TransIT–DNA
complexes and 24 h later used for transduction assays
(see below).
To assess the effect of tunicamycin treatment on the
susceptibility of NIH 3T3, F10, and XC cells to the eco-
tropic virus vector, the cells (105) were seeded in 60-mm
culture dishes and the following day, tunicamycin at the
indicated final concentration was added. The culture
medium was removed 24 h later and the cells were used
for transduction assays (see below).
Transduction assay
The ecotropic retrovirus vector was generated by sta-
ble transfection of TELCeB6 cells, which express the
Mo-MLV gag and pol genes and the retroviral vector
genome containing Escherichia coli lacZ (Cosset et al.,
1995), with the wild-type Mo-MLV Env expression plas-
mid. Cultures of NIH 3T3, F10, XC, CHO, and transfected
CHO cells were exposed to the virus vector for 24 h in the
presence of polybrene (4 g/ml). After culturing for an
additional 24 h in fresh medium, the cells were stained
with 5-bromo-4-chloro-3-indolyl -D-galactopyranoside
(X-Gal), and the blue cells were counted under a micro-
scope to estimate the transduction titer.
Syncytium formation assay
The expression plasmids encoding the wild-type Mo-
MLV Env protein (R Env) or Env lacking the R peptide
(R Env) were transfected into 293T cells using the
TransIT-LT1 reagent. The plasmid encoding the R Env
protein was constructed by the PCR-based method using
a mutant oligonucleotide that substitutes the codon for
valine at amino acid position 617 by the termination
codon. Two days after transfection, aliquots of the 293T
cells were inoculated onto confluent cultures of the tar-
get cells. These cells were fixed and stained with 1%
methylene blue in methanol 24 h later.
Accession number
The DDBJ/GenBank/EMBL Accession No. for nucleo-
tide sequence of xcCAT1 cDNA is AB066224.
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